Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Human hair growth is influenced by androgen hormones, and red deer mane follicles have similar hormone receptors.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Human keratinocytes do not naturally respond to androgens.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Minoxidil can reduce functions related to androgen receptors.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

5α-reductases increase epitestosterone's effect on androgen receptors.

Finasteride side effects in young men may be linked to specific gene variations.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Androgens improve memory in adolescent male rats by acting on brain receptors.